What is the impact of preventive therapies on the performance of the American Heart Association- American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort?
A study conducted by DeFilippis et al. (2017) found that preventive therapies can lead to an overestimation of the American Heart Association- American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort. The study found that the use of preventive therapies such as statins and antihypertensives could lead to a 10-20% overestimation of the risk score. The study concluded that the use of preventive therapies should be taken into consideration when assessing the cardiovascular risk of a patient.